SEC Form D · filed November 9, 2016
IRX Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (29)
Charles R. Cherington · New York, NYDirectorZygmund P. Roth · New York, NYExecLawrence M. Wolf · New York, NYDirectorFerid D. Murad · New York, NYDirectorJohn W. Hadden Ii · New York, NYExec · DirectorGeorge P. Denny Iii · New York, NYDirectorDavid H. Deming · New York, NYDirectorJohn D. Halpern · New York, NYDirectorCurtis P. Robb · New York, NYExecJeffrey Hwang · New York, NYExecBrad Beasecker · Columbus, OHDirectorDennis Townsend · Louisville, CODirectorDavid King · Louisville, CODirectorBill Flecky · Louisville, COExecJack Mcfarland · Louisville, CODirectorPaul Lichty · Louisville, CODirectorJames Trevey · Louisville, COExec · DirectorGanesh H. Betanabhatla · Houston, TXExecAlexandra Waldman · New York, NYDirectorJerod Bowen · Chandler, AZExecJared D. Levin · Richmond, VADirectorMax D. Comess · Richmond, VADirectorAileen S. O'Toole · Amsterdam, P7DirectorLawrence C. Illg · Incline Village, NVDirectorGary Rojewski · Las Vegas, NVExec · DirectorJohn D. Harper · Las Vegas, NVDirectorJohn W. Copeland · Palm Beach, FLDirectorRichard S. Berg · Chicago, ILExecDavid F. Wilding · Chicago, ILExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗